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Background
The need for human mesenchymal stem cells (hMSCs)
has increased enormously in recent years due to their
important therapeutic potential. Efficient cell expansion
is essential to providing clinically relevant cell numbers.
Such cell quantities can be manufactured by means of
scalable microcarrier (MC)-supported cultivations in
stirred single-use bioreactors.
Materials and methods
Preliminary tests in disposable-spinners (100 mL culture
volume, Corning) were used to determine two suitable
media and MC-types for serum reduced expansions
(< 10%) of human adipose tissue-derived stem cells
(hADSCs; passage 2, Lonza). Using such optimized
media-MC-combinations, hADSCs expanded 30 to 40-
fold, which compares well with expansion rates in planar
culture. Based on computational fluid dynamics simula-
tions and suspension analyses in spinners [1], optimal
operating parameters were determined in a BIOSTAT®
UniVessel® SU 2 L (2 L culture volume, Sartorius Stedim
Biotech).
Results
In subsequent batch tests with the BIOSTAT UniVessel®
SU 2 L, expansion rates of between 30 and 40-fold were
reached and up to 4.4·108 cells with a cell viability
exceeding 98% were harvested. Flow cytometry tests
demonstrated typical marker profiles following cell
expansion and harvest. A 40-fold expansion rate
delivered a total of 1·1010 cells in a first cultivation
with the BIOSTAT® CultiBag STR 50 L (35 L culture
volume, Sartorius Stedim Biotech).
Conclusions
In summary, the foundations for successfully expanding
therapeutic stem cells in truly scalable systems have
been laid. Strategies ensuring expansion rates between
60 and 70-fold and, thus, generating cell amounts over
1010 are now in preparation.
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